Allogene Therapeutics, Inc.
ANTIBODIES AGAINST 4G7-DERIVED CHIMERIC ANTIGEN RECEPTORS
Last updated:
Abstract:
Provided herein are isolated antibodies that specifically bind anti-CD19 chimeric antigen receptors (CARs) derived from a 4G7 scFv. Also provided are methods of making and using these isolated antibodies.
Status:
Application
Type:
Utility
Filling date:
17 Apr 2020
Issue date:
22 Oct 2020